The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

ALBANY, N.Y. ( NEWS10) — A new device is transforming the type of treatment some heart patients with atrial fibrillation receive. Doctors say it’s safer to use and improving outcomes for those who ...

At 3 years old Logan McLennan was focused and observant and had a single question for his parents before he was taken to the operating room at Boston Children’s Hospital for six hours of open-heart ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Conformal Medical today announced on social media that the first U.S. site enrolled a patient in a trial of its next-gen ...

Kathy Davis of Canonsburg underwent heart surgery, but complications left her with right heart failure, a condition where the ...

When it comes to heart health, the prevalence of a condition shouldn’t be much of a comfort for those dealing with symptoms. While it’s always good to ...

Anyone who meets Katie Eddington would likely consider her the picture of optimal health. When she studied sports medicine at ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

Understanding key concepts in Physics, Chemistry, and Biology can be challenging for many Class 10 students. However, ...